Govt Job for Ph.D, M.Pharm, M.Sc as Research Associate at PGIMER

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab and the distinguished medical educationists of the then combined state of Punjab, supported by the first Prime Minister of India Pt. Jawahar Lal Nehru who considered the institutions of scientific knowledge as temples of learning and the places of pilgrimage.

A Research Associate is required in the research project entitled, “Development of personalized radiation treatment regime using Radio-genomics based radiation toxicity prediction model in Head Neck Squamous Cell Carcinoma (HNSCC)” funded by ICMR, New Delhi in Department of Biochemistry, PGIMER, Chandigarh.

Post : Research Associate

Essential qualification :PhD / MD / MS or Equivalent degree or having 3 years of research and/or teaching with at least one research paper in Science Citation Indexed (SCI) journal
Age : As per ICMR rules (Relaxation will be given to women/SC/ST/OBC/PWD candidates as per rules)
Desirable : Experience in NGS data analysis and Statistical methods for developing risk prediction models

Salary/Stipend : Rs. 47,000/- + HRA @16% i.e. Rs. 7,520 p.m
Tenure : Initially for 1 year to be extended till the tenure of the project subject to the performance of the candidate

Interested candidates are requested to send detailed CV to the undersigned through e-mail ID: Iab320pgi@gmail.com.
Online interview : Shortlisted candidates will be intimated through e-mail. Interview will be on Zoom/Google meet platform

Last date of submission of CV :June 9, 2021

Related Posts

‘Drug companies in upgrade mode need more time for GMP compliance’: IDMA

New Delhi: A pharma group has sought extension for those production units that have already submitted upgradation plans and can demonstrate execution progress, even as the drug regulatory authority seems…

Obesity treatment drugs to be new growth engine for pharma industry: Sun Pharma

New Delhi: Improving access to new age medicines for obesity and diabetes over the next few years would be a key enabler for the growth of the domestic pharmaceutical industry,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

‘Drug companies in upgrade mode need more time for GMP compliance’: IDMA

‘Drug companies in upgrade mode need more time for GMP compliance’: IDMA

Obesity treatment drugs to be new growth engine for pharma industry: Sun Pharma

Obesity treatment drugs to be new growth engine for pharma industry: Sun Pharma

National Pharmaceutical Pricing Authority fixes retail price of 37 new drugs

National Pharmaceutical Pricing Authority fixes retail price of 37 new drugs

Massive Drug Bust in Bijnor: CBN Seizes Over 6.5 Lakh Tablets

Massive Drug Bust in Bijnor: CBN Seizes Over 6.5 Lakh Tablets

Sun Pharma unit recalls 17,000-plus bottles of antifungal shampoo in US

Sun Pharma unit recalls 17,000-plus bottles of antifungal shampoo in US

Strides Pharma Science arm New York facility gets 4 USFDA observations

Strides Pharma Science arm New York facility gets 4 USFDA observations